National Health Investors, Inc. reported first quarter 2022 results, featuring a net income attributable to common stockholders of $0.18 per diluted common share, NAREIT FFO per diluted common share of $1.05, and Normalized FFO per diluted common share of $1.10. The company sold two properties for approximately $13.7 million and is making progress on portfolio optimization.
Net income attributable to common stockholders per diluted common share was $0.18.
NAREIT FFO per diluted common share was $1.05.
Normalized FFO per diluted common share was $1.10.
Normalized FAD was $52.7 million.
The Company reiterates the guidance it issued in a press release dated April 18, 2022. A summary of the guidance includes the following: •NAREIT FFO per diluted common share in a range of $4.32 – $4.42 •Normalized FFO per diluted common share in a range of $4.38 – $4.48 •Funds Available for Distribution in a range of $201.8 million - $206.4 million •Weighted average diluted common shares of 45.9 million